Phase Ib trial of APD 811 in volunteers.

Trial Profile

Phase Ib trial of APD 811 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 May 2017

At a glance

  • Drugs Ralinepag (Primary)
  • Indications Pulmonary hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Arena Pharmaceuticals
  • Most Recent Events

    • 24 May 2017 Results (n=50) presented at the 113th International Conference of the American Thoracic Society
    • 16 May 2017 According to an Arena Pharmaceuticals media release, data from this trial will be presented at the American Thoracic Society (ATS) 2017 International Conference.
    • 14 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top